threo-4-oxo-(3-Acetyl)-AHPA can be used in the synthesis of ubenamide intermediates.
threo-4-oxo-(3-Acetyl)-AHPA is a specialized chiral intermediate primarily utilized in the synthesis of complex pharmaceutical agents. The compound features a specific stereochemical configuration essential for bioactivity, typically produced via asymmetric catalytic hydrogenation or enzymatic resolution. While exact molecular formula and CAS number require verification against proprietary databases, this precursor serves as a critical building block for advanced drug development pipelines.
Strict adherence to safety data sheets is mandatory during handling. Storage requires cool, dry conditions under inert atmosphere to prevent racemization or degradation. Personnel must utilize appropriate PPE to avoid inhalation or skin contact, ensuring compliance with global chemical safety regulations.